Neurology
Conference Coverage
Adding CGRP to Botox is safe and effective for migraine prevention
Conference Coverage
NSAID/triptan combination improves treatment-resistant migraine
A combination of rizatriptan and meloxicam formulated to improve oral absorption led to better outcomes than rizatriptan alone.
Conference Coverage
CGRPs in real world: Similar efficacy, more AEs
A real-world study of monoclonal antibody agents reported comparable efficacy but more adverse events than clinical trials.
Conference Coverage
Intranasal DHE shows promise in migraine
New formulation of DHE joins other efforts to improve delivery of existing drugs.
Conference Coverage
Persistent posttraumatic headache risk factors confirmed
An analysis of 300 patients with posttraumatic headache reveals some long-suspected risk factors of persistent headache, but also a high...
Conference Coverage
Few patients with migraine clear barriers to optimal care
Less than 8% of patients with episodic migraine and less than 2% of patients with chronic migraine were able to overcome four key treatment...
Conference Coverage
Population study supports migraine–dementia link
Migraine with aura confers a significantly higher risk of dementia, according to preliminary findings from a population-based cohort study in...
Conference Coverage
Cannabis misconceptions still common among MS clinicians
Studies and surveys underscore that misconceptions about cannabis could be common among clinicians and patients.
Commentary
I’m getting old (and it’s costing me)
I was told that my insurance premium would jump to more than 4 times the previous premium because of a CAC score of 22.
News
COVID-19 neurologic effects: Does the virus directly attack the brain?
There are neurologic sequelae of COVID-19. “We need to be alert to these, and to try to understand the potential long-term consequences.”
Latest News
Antenatal corticosteroids may increase risk for mental and behavioral disorders
A Finnish population-based study raises questions about expanded use of the therapy.